The ARK Genomic Revolution ETF is up about 5.4% on the day, signaling strong risk-on flow into genomic and biotech names. Key holdings showing outsized strength include Twist Bioscience, up about 13.8%, and Pacific Biosciences of California, up about 8.6%. The move appears driven by sector momentum rather than company-specific news.
The ARK Genomic Revolution ETF is up about 5.4% on the day, signaling strong risk-on flow into genomic and biotech names. Key holdings showing outsized strength include Twist Bioscience, up about 13.8%, and Pacific Biosciences of California, up about 8.6%. The move appears driven by sector momentum rather than company-specific news.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.45
Ticker Sentiment
